FDA Clears New AI-Powered MRI System from Fujifilm
The Echelon Synergy MRI system reportedly uses deep learning technology to accelerate image acquisition and enhance image quality.
The Food and Drug Administration (FDA) has granted 510(k) clearance for the Echelon Synergy magnetic resonance imaging (MRI) system, which combines artificial intelligence (AI) enhancements for image acquisition and quality with improved radiology workflow efficiencies.
The Echelon Synergy MRI system utilizes proprietary Deep Learning Reconstruction technology to improve the quality of MRI scans and the speed of acquiring the images, according to Fujifilm Healthcare Americas Corporation, the manufacturer of the new 1.5 Tesla MRI system.
One key benefit of the Echelon Synergy MRI system is the AutoExam One Touch, which allows automated workflows for brain and knee MRI exams.
In order to facilitate improved patient comfort, Fujifilm said the Echelon Synergy system offers reduced acoustic noise through SoftSound™ gradient technology as well as a 70 cm-wide bore and 62 cm-wide table that can accommodate patients weighing up to 550 pounds.
“Fujifilm is committed to delivering medical advancements focused on enhancing the patient’s experience while streamlining the workflow for today’s busy imaging providers,” noted Shawn Etheridge, the executive director of modality solutions for Fujifilm Healthcare Americas Corporation.
“Echelon Synergy is designed to facilitate optimal comfort and help alleviate anxiety with its large bore and wide patient table. Alleviating any patient anxiety not only helps to enhance the patient experience, but could also improve a radiologist’s workflow, as the less nervous a patient, the more efficient and quickly the scan will get done.”
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
